ResearcherZhejiang Provincial People's HospitalActive in the last 2 years
Wanyuan Chen
Matched on ORCID iD 0000-0002-8216-9568; OpenAlex author ID A5004424210. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- [Corrigendum] Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic canc… Co-author DOI 10.3892/or.2025.9013↗
- Expression of Spindle and Kinetochore-related Complex Subunit 3 is Associate With the Progression and Prognosis of Hepatocellular Carcinoma and Pancreatic Aden… Co-author DOI 10.21203/rs.3.rs-40794/v1↗
- Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancer. Co-author DOI 10.3892/or.2018.6817↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shibing Wang · 3 shared papers, 2019–2026 · strength 0.53
- Paper [Corrigendum] Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effec… DOI 10.3892/or.2025.9013↗
- Paper Expression of Spindle and Kinetochore-related Complex Subunit 3 is Associate With the Progression and Prognosis of Hepa… DOI 10.21203/rs.3.rs-40794/v1↗
- Paper Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor… DOI 10.3892/or.2018.6817↗
- Weimin Fan · 2 shared papers, 2019–2026 · strength 0.42
- Paper [Corrigendum] Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effec… DOI 10.3892/or.2025.9013↗
- Paper Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor… DOI 10.3892/or.2018.6817↗
- Kuiwei Su · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.